|
+ |
|
→ |
|
+ | UDP |
|
+ |
|
→ |
|
+ | UDP |
* Produces type 1 chain linkage in glycolipids and core-3 O-glycans, but not N-linked glycoproteins.
* May be an important enzyme forming CA19-9 in colon cancer. Beyond serving as a biomarker, CA19-9 also promotes pancreatitis and pancreatic cancer (in mice).
* B3GalT5 efficiently transfers Gal to the GlcNAc of the glycolipid Lc3Cer and to the terminal GalNAc residue of the globoside Gb4.
* It may thus contribute to the formation of CA 19-9, SSEA-3 and elongated core-3 O-glycans.
* Expression is restricted to the colorectum, small intestine, stomach, and pancreas.
ER | Cis- | Medial- | Trans- | TGN |
---|---|---|---|---|
B3GALT5/hsa-miR-323a-5p |
---|
miRNA Target | Site Type | Pos. | Context Score | Frac. | Wt. Context | Frac. | Conserved | Quality |
---|---|---|---|---|---|---|---|---|
5'...ACCUGAGACUCCAA
GACCACCA
... 3' CGCUUGCGCGGUGC CUGGUGG A |
8mer | 6834-6841 | -0.274 | 94.0 | -0.274 | 95.0 | noncon | |
5'...UGCCCCUCCACUGC
GACCACC
C... 3' CGCUUGCGCGGUGC CUGGUGG A |
7mer-m8 | 3788-3794 | -0.119 | 77.0 | -0.119 | 84.0 | noncon | |
5'...GAUUAUAGGCAUGC
ACCACCA
A... 3' CGCUUGCGCGGUGCC UGGUGG A |
7mer-A1 | 4953-4959 | -0.032 | 43.0 | -0.032 | 58.0 | noncon |